Zhiyong Liu

ORCID: 0000-0002-5392-9230 · 17 papers in corpus · active 2019-2026

Study types

  • dataset 6
  • article 5
  • other 2
  • preprint 2
  • review 1

Condition tags

  • adenomyosis 15
  • endometriosis 1
  • infertility 1
other 2026
BMC women's health ·doi:10.1186/s12905-026-04415-0

BACKGROUND: Synchronous multiple primary malignancies (SMPMs) involving the uterus and ovary pose significant diagnostic challenges, particularly in distinguishing independent primary tumors from metastatic disease when tumors exhibit overl…

review 2026
International journal of molecular medicine ·doi:10.3892/ijmm.2026.5778

Adenomyosis (AM), an estrogen‑dependent chronic inflammatory disease with a rising incidence, has emerged as a major cause of infertility and reduced clinical pregnancy rates in reproductive‑aged women, severely impairing reproductive healt…

preprint 2025
·doi:10.2139/ssrn.5517124
article 2024
Phytomedicine : international journal of phytotherapy and phytopharmacology ·doi:10.1016/j.phymed.2024.155461

BACKGROUND: The active ingredients of the Chinese medical herb Paris polyphylla, P. polyphylla ethanol extract (PPE) and polyphyllin I (PPI), potentially inhibit epithelial-mesenchymal transition (EMT) in tumors. However, the roles of these…

article 2023
Tissue & cell ·doi:10.1016/j.tice.2023.102284

Because adenomyosis (AM) ectopic primary cells are hard to come by, have a short lifespan, and the characteristics that alter over time, their utility in AM research is constrained. This study aimed to establish a line of immortalized human…

article 2023
Journal of inflammation research ·doi:10.2147/jir.s402734

PURPOSE: Adenomyosis (AM) is a common benign uterine disorder that has deleterious effects on women's health. However, the pathogenesis of AM is not clearly understood. We aimed to investigate the pathophysiological changes and molecular me…

other 2022
Evidence-based complementary and alternative medicine : eCAM ·doi:10.1155/2022/6350257

BACKGROUND: The effect of GuizhiFuling Wan (GFW) on adenomyosis (AM) is definite. This study aimed to explore the mechanism and key therapeutic targets of GFW in treating AM through network pharmacology combined with molecular docking and e…

article 2022
Evidence-based complementary and alternative medicine : eCAM ·doi:10.1155/2022/2624434

OBJECTIVE: To explore the molecular mechanism of the Cinnamomi ramulus and Paris polyphylla Sm. (C-P) drug pair in the treatment of adenomyosis (AM) based on network pharmacology and animal experiments. METHODS: Via a network pharmacology …

dataset 2021
·doi:10.6084/m9.figshare.14183837

Additional file 1: Figure S1. HE staining and QC. (A) Samples from the AM_CTRL, AM_EM and AM_EC groups were HE stained, and the black arrow shows the gland invading the muscular layer. (B) X axis represents the number of UMI in each cell, a…

dataset 2021
·doi:10.6084/m9.figshare.14183840

Additional file 2: Table S1. Doublet score and predicted doublets.

dataset 2021
·doi:10.6084/m9.figshare.14183843

Additional file 3: Table S2. DEGs of AM_EC vs. AM_EM (all cell types).

dataset 2021
·doi:10.6084/m9.figshare.14183846

Additional file 4: Table S3. Coexisting genes in Venn.

dataset 2021
·doi:10.6084/m9.figshare.14183849

Additional file 5: Table S4. DEGs of AM_EC vs. AM_EM (epithelial cells).

dataset 2021
·doi:10.6084/m9.figshare.14183852

Additional file 6: Table S5. Clinical characteristics of AM patients and hysteromyoma samples used in this study.

article 2021
Cell & bioscience ·doi:10.1186/s13578-021-00562-z

BACKGROUND: Adenomyosis (AM) is a common benign chronic gynaecological disorder; however, the precise pathogenesis of adenomyosis is still poorly understood. Single-cell RNA sequencing (scRNA-seq) can uncover rare subpopulations, explore ge…

preprint 2020
·doi:10.21203/rs.3.rs-127243/v1
2019
·doi:10.21203/rs.2.19512/v1